Overview
The breast programme covers screening-detected lesions, invasive ductal and lobular carcinoma, ductal carcinoma in situ, and recurrent disease. Core biopsy with receptor testing (ER, PR, HER2, Ki-67) guides the entire plan.
Treatment pathways
Care may include surgery, image-guided ablation for selected small tumours, systemic therapy, and radiation planning. Fertility preservation and genetic counselling (BRCA1/2) are offered before treatment starts when relevant.
Recovery and support
Patients receive wound-care guidance, lymphoedema screening, and a structured survivorship schedule. A dedicated international-patient coordinator manages appointments so treatment is not delayed by travel logistics.
Still have questions?
Reach our care team for personalized guidance on diagnosis, treatment, and insurance.
